適時開示情報
- 2024/04/12
- Notice Regarding Impairment Loss for intangible assets, Change in fair value of contingent consideration, and Revision of Financial Forecasts for FY23
- 2024/04/01
- U.S. FDA Accepts Astellas’ Supplemental New Drug Application for IZERVAY (avacincaptad pegol intravitreal solution) for Geographic Atrophy
TD-net(適時開示情報閲覧サービス)にて開示された情報を掲載しております。